Document Detail


Identification of ellagic acid as potent inhibitor of protein kinase CK2: a successful example of a virtual screening application.
MedLine Citation:
PMID:  16610779     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Casein kinase 2 (CK2) is a ubiquitous, essential, and highly pleiotropic protein kinase whose abnormally high constitutive activity is suspected to underlie its pathogenic potential in neoplasia and other diseases. Using a virtual screening approach, we have identified the ellagic acid, a naturally occurring tannic acid derivative, as a novel potent CK2 inhibitor. At present, ellagic acid represents the most potent known CK2 inhibitor (K(i) = 20 nM).
Authors:
Giorgio Cozza; Paolo Bonvini; Elisa Zorzi; Giorgia Poletto; Mario A Pagano; Stefania Sarno; Arianna Donella-Deana; Giuseppe Zagotto; Angelo Rosolen; Lorenzo A Pinna; Flavio Meggio; Stefano Moro
Related Documents :
20501999 - Small molecule inhibitors of acid sphingomyelinase.
24144809 - 2,3-butanediol recovery from fermentation broth by alcohol precipitation and vacuum dis...
19460009 - Antibacterial properties of soap containing some fatty acid esters.
17644399 - Antitumor studies. part 3: design, synthesis, antitumor activity, and molecular docking...
11558589 - Synthesis and cytotoxic activity of benzophenanthrolinone analogues of acronycine.
9495589 - Synthesis and study of normal, enantio, retro, and retroenantio isomers of cecropin a-m...
1783489 - Acid-base properties of thymopoietin-type tri- and tetrapeptides and their derivatives.
12197069 - Solid-phase synthesis of tetrahydro-1,4-benzodiazepin-2-one derivatives.
2308329 - The relationship of free fatty acids with the binding of oestradiol to shbg and to albu...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of medicinal chemistry     Volume:  49     ISSN:  0022-2623     ISO Abbreviation:  J. Med. Chem.     Publication Date:  2006 Apr 
Date Detail:
Created Date:  2006-04-13     Completed Date:  2006-05-22     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  9716531     Medline TA:  J Med Chem     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2363-6     Citation Subset:  IM    
Affiliation:
Molecular Modeling Section, Dipartimento di Scienze Farmaceutiche, Università di Padova, via Marzolo 5, Padua, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Binding Sites / drug effects
Casein Kinase II / antagonists & inhibitors*
Cell Survival / drug effects
Drug Evaluation, Preclinical / methods
Ellagic Acid / chemistry,  pharmacology*
Enzyme Activation / drug effects
Enzyme Inhibitors / chemistry,  pharmacology*
Humans
Kinetics
Models, Molecular
Structure-Activity Relationship
Chemical
Reg. No./Substance:
0/Enzyme Inhibitors; 476-66-4/Ellagic Acid; EC 2.7.11.1/Casein Kinase II

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Trauma care: an exceptional delivery system.
Next Document:  Biosensor-based kinetic characterization of the interaction between HIV-1 reverse transcriptase and ...